Cargando…
Retrospective Analysis of Checkpoint Inhibitor Therapy-Associated Cases of Bullous Pemphigoid From Six German Dermatology Centers
Immune-related adverse events (irAEs) are a class-effect of checkpoint inhibitors (CIs). The development of a Bullous pemphigoid (BP)-like blistering disease, driven by autoantibodies against the hemidesmosomal protein BP180, is a potentially serious irAE whose incidence seems to be increasing. We t...
Autores principales: | Sadik, Christian D., Langan, Ewan A., Gutzmer, Ralf, Fleischer, Maria Isabel, Loquai, Carmen, Reinhardt, Lydia, Meier, Friedegund, Göppner, Daniela, Herbst, Rudolf A., Zillikens, Detlef, Terheyden, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940359/ https://www.ncbi.nlm.nih.gov/pubmed/33708189 http://dx.doi.org/10.3389/fimmu.2020.588582 |
Ejemplares similares
-
Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid
por: Sadik, Christian D., et al.
Publicado: (2019) -
Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans
por: Russlies, Juliane, et al.
Publicado: (2019) -
Diagnosis and clinical severity markers of bullous pemphigoid
por: Schmidt, Enno, et al.
Publicado: (2009) -
Generalized morphoea in the setting of combined immune checkpoint inhibitor therapy for metastatic melanoma: A case report
por: Langan, Ewan A., et al.
Publicado: (2021) -
Resolution in bullous pemphigoid
por: Sadik, Christian D., et al.
Publicado: (2019)